GlassScriptPhysician profile
Ilyas Munshi
NPI 1740397306
$4,643.32
in general payments reported to CMS, 2019-2025
29 companies · $309 in 2025
The $309 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,197 · 2020: $1,883 · 2021: $137 · 2022: $258 · 2023: $364 · 2024: $496 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,169.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,689.49 | 2019-2020 | |
| Stryker Corporation | $1,065.53 | 2019-2025 | Universal Neuro 3 |
| Medtronic, INC. | $552.96 | 2022-2025 | Unid_pass, Pipeline, Mazor X System |
| Providence Medical Technology, INC. | $246.22 | 2021-2024 | |
| Depuy Synthes Sales INC. | $138.71 | 2019-2020 | |
| Boston Scientific Corporation | $105.99 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Ulrich Medical USA, INC. | $98.28 | 2023 | |
| Nico Corporation | $97.54 | 2024 | |
| Centinel Spine, LLC | $74.86 | 2020 | |
| Aesculap, INC. | $73.40 | 2020-2022 | |
| Camber Spine Technologies LLC | $59.67 | 2019 | |
| Globus Medical, INC. | $46.76 | 2025 | Xlif |
| Alon Medical Technology | $39.48 | 2025 | |
| Integra Lifesciences Corporation | $38.85 | 2022 | |
| Innovation Technologies INC | $38.53 | 2025 | Irrisept |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $36.06 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Graftguide |
| Kowa Pharmaceuticals America, INC. | $34.45 | 2023 | Seglentis |
| Nevro Corp. | $24.54 | 2024 | Senza |
| Pacira Pharmaceuticals Incorporated | $22.80 | 2024 | Exparel |
| Novocure INC. | $20.78 | 2024 | Optune |
| Seaspine Orthopedics Corporation | $19.95 | 2019 | |
| Omniscient Neurotechnology America LTD | $18.23 | 2023 | Quicktome |
| Relievant Medsystems, INC. | $18.12 | 2021 | |
| Convatec INC. | $16.52 | 2024 | |
| Arbor Pharmaceuticals, INC. | $14.94 | 2020 | |
| Arteriocyte Medical Systems, INC. | $14.05 | 2022 | |
| Baudax Bio INC. | $13.63 | 2022 | |
| Bioventus LLC | $11.95 | 2022 | |
| Si-Bone, INC. | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ilyas Munshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.